Filing Details
- Accession Number:
- 0001104659-24-025663
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-20 18:56:43
- Reporting Period:
- 2024-02-16
- Accepted Time:
- 2024-02-20 18:56:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1773427 | Springworks Therapeutics Inc. | SWTX | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1819465 | Daniel Pichl | C/O Springworks Therapeutics, Inc. 100 Washington Blvd. Stamford CT 06902 | Chief People Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-02-16 | 15,000 | $27.64 | 60,212 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-02-16 | 15,000 | $50.10 | 45,212 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-02-16 | 15,000 | $0.00 | 15,000 | $27.64 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 45,000 | 2033-01-05 | No | 4 | M | Direct |
Footnotes
- The transactions reported on this Form 4 were effected pursuant to a trading plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, adopted on March 9, 2023.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.35. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- This option shall vest in 48 equal monthly installments subject to continued service to the Issuer by the Reporting Person.
Billionaire Hedge Funds
